Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries Article

Cardona, Andres F, Arrieta, Oscar, Ruiz-Patino, Alejandro et al. (2020). Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries . 14 10.1177/1753466620938553

Open Access Industry Collaboration International Collaboration

cited authors

  • Cardona, Andres F; Arrieta, Oscar; Ruiz-Patino, Alejandro; Sotelo, Carolina; Zamudio-Molano, Nataly; Zatarain-Barron, Zyanya Lucia; Ricaurte, Luisa; Raez, Luis; alvarez, Marco Polo Peralta; Barron, Feliciano; Rojas, Leonardo; Rolfo, Christian; Karachaliou, Niki; Molina-Vila, Miguel Angel; Rosell, Rafael

fiu authors

publication date

  • July 1, 2020

keywords

  • ANTITUMOR-ACTIVITY
  • CANCER GENOMES
  • GENOMIC MEDICINE
  • INHIBITOR
  • LAROTRECTINIB
  • Life Sciences & Biomedicine
  • NTRK
  • ONCOGENE
  • ONCOLOGY
  • PAN-TRK
  • REARRANGEMENTS
  • Respiratory System
  • Science & Technology
  • TROPOMYOSIN
  • larotrectinib
  • precision medicine
  • tropomyosin receptor kinase family

Digital Object Identifier (DOI)

volume

  • 14